Hema Now
In this episode of Hema Now, Ana Boban discusses her vision as the incoming European Association for Haemophilia and Allied Disorders (EAHAD) President for 2026–2028. From her early experiences in haemophilia care to her leadership in European clinical trials and guideline development, she reflects on the future of bleeding disorders in Europe, highlighting the importance of supporting young clinicians and researchers, advancing clinical practice, and driving innovation in haemophilia care and research.
Spotify | Apple | Amazon Music | YouTube | Download MP3 (24 mins)
Ana Boban is a Consultant Haematologist at the University Hospital Centre Zagreb, Croatia, and a leading researcher in haemophilia and rare bleeding disorders. She has played a key role in European clinical trials and guideline development and now begins her term as the EAHAD President for 2026–2028.
Timestamps:
00:00 – Introduction
01:38 – Vision for EAHAD Presidency
03:50 – Building on Past Leadership
06:45 – Key Priorities: Practice, Research, Education
09:05 – EAHAD Congress Highlights
11:20 – European Haemophilia Landscape Today
14:17 – Advances Influencing Clinical Care
16:14 – Unmet Needs in Europe
17:45 – Supporting Young Clinicians, Researchers
20:00 – Long-Term Goals Beyond 2028
TBC- Three Wishes for Haemophilia
Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.
